S100A8/S100A9 cytokine acts as a transcriptional coactivator during breast cellular transformation.


Journal

Science advances
ISSN: 2375-2548
Titre abrégé: Sci Adv
Pays: United States
ID NLM: 101653440

Informations de publication

Date de publication:
01 2021
Historique:
received: 27 08 2020
accepted: 05 11 2020
entrez: 1 2 2021
pubmed: 2 2 2021
medline: 16 4 2022
Statut: epublish

Résumé

Cytokines are extracellular proteins that convey messages between cells by interacting with cognate receptors at the cell surface and triggering signaling pathways that alter gene expression and other phenotypes in an autocrine or paracrine manner. Here, we show that the calcium-dependent cytokines S100A8 and S100A9 are recruited to numerous promoters and enhancers in a model of breast cellular transformation. This recruitment is associated with multiple DNA sequence motifs recognized by DNA binding transcription factors that are linked to transcriptional activation and are important for transformation. The cytokines interact with these transcription factors in nuclear extracts, and they activate transcription when artificially recruited to a target promoter. Nuclear-specific expression of S100A8/A9 promotes oncogenic transcription and leads to enhanced breast transformation phenotype. These results suggest that, in addition to its classical cytokine function, S100A8/A9 can act as a transcriptional coactivator.

Identifiants

pubmed: 33523865
pii: 7/1/eabe5357
doi: 10.1126/sciadv.abe5357
pmc: PMC7775746
pii:
doi:

Substances chimiques

Calgranulin A 0
Calgranulin B 0
Cytokines 0
S100A8 protein, human 0
S100A9 protein, human 0
Transcription Factors 0

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NCI NIH HHS
ID : R01 CA107486
Pays : United States

Informations de copyright

Copyright © 2021 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works. Distributed under a Creative Commons Attribution License 4.0 (CC BY).

Références

Mol Cell. 2006 Dec 8;24(5):747-757
pubmed: 17157257
Nat Immunol. 2009 Apr;10(4):333-9
pubmed: 19295629
Proc Natl Acad Sci U S A. 2019 May 7;116(19):9453-9462
pubmed: 30910960
Oncogene. 2016 Nov 3;35(44):5735-5745
pubmed: 27086923
Nat Methods. 2012 Mar 04;9(4):357-9
pubmed: 22388286
Nat Commun. 2018 May 25;9(1):2068
pubmed: 29802342
J Mol Biol. 2006 Jun 16;359(4):961-72
pubmed: 16690079
Carcinogenesis. 2008 Oct;29(10):2035-43
pubmed: 18689872
Cell. 2002 Apr;109 Suppl:S121-31
pubmed: 11983158
Elife. 2020 Apr 07;9:
pubmed: 32255429
J Biol Chem. 2002 Aug 9;277(32):28815-22
pubmed: 12052832
Cancer Cell. 2010 Apr 13;17(4):348-61
pubmed: 20385360
Nat Rev Cancer. 2015 Feb;15(2):96-109
pubmed: 25614008
Science. 2015 Jan 23;347(6220):1260419
pubmed: 25613900
Nucleic Acids Res. 2016 Jul 8;44(W1):W160-5
pubmed: 27079975
Genome Biol. 2009;10(3):R25
pubmed: 19261174
Cell. 2010 Apr 30;141(3):432-45
pubmed: 20434984
Nature. 2012 Jan 04;481(7381):389-93
pubmed: 22217937
Cell Rep. 2014 May 22;7(4):1020-9
pubmed: 24794443
Nature. 2013 Feb 21;494(7437):375-9
pubmed: 23354051
Cell. 2009 Nov 13;139(4):693-706
pubmed: 19878981
Circulation. 2015 Mar 3;131(9):795-804
pubmed: 25637627
J Immunol. 1990 Feb 15;144(4):1295-303
pubmed: 2137488
Biochim Biophys Acta. 2013 Jan;1835(1):100-9
pubmed: 23123827
Nucleic Acids Res. 2020 Jan 8;48(D1):D87-D92
pubmed: 31701148
Biochem Biophys Res Commun. 2014 Aug 15;451(1):8-14
pubmed: 25003325
Nature. 2012 Oct 4;490(7418):61-70
pubmed: 23000897
Oncogene. 2011 May 5;30(18):2161-72
pubmed: 21242971
Cell. 2013 Nov 7;155(4):934-47
pubmed: 24119843
Cell. 2013 Sep 26;155(1):39-55
pubmed: 24074860
Oncol Rep. 2017 Jun;37(6):3361-3368
pubmed: 28498439
Proc Natl Acad Sci U S A. 2004 Feb 24;101(8):2434-9
pubmed: 14983027
Elife. 2015 Nov 21;4:e10870
pubmed: 26590320
Elife. 2015 Dec 19;4:e08890
pubmed: 26687005
Nat Rev Immunol. 2005 Apr;5(4):331-42
pubmed: 15803152
Nucleic Acids Res. 2019 Jan 8;47(D1):D506-D515
pubmed: 30395287
Mol Cancer Res. 2011 Feb;9(2):133-48
pubmed: 21228116
J Clin Oncol. 2009 Mar 10;27(8):1160-7
pubmed: 19204204
Hypertension. 1999 Oct;34(4 Pt 1):534-8
pubmed: 10523322
Cell. 2013 Apr 11;153(2):307-19
pubmed: 23582322
Bioinformatics. 2013 Feb 15;29(4):420-7
pubmed: 23267173
J Genet Genomics. 2017 Feb 20;44(2):119-121
pubmed: 28162959
Nat Med. 2007 Sep;13(9):1042-9
pubmed: 17767165
Curr Protoc Bioinformatics. 2009 Sep;Chapter 13:Unit 13.11
pubmed: 19728287
Mol Cell. 2010 May 28;38(4):576-89
pubmed: 20513432
Immunity. 2013 Dec 12;39(6):1171-81
pubmed: 24332034
Mol Cell. 2010 Aug 27;39(4):493-506
pubmed: 20797623
Biochem Pharmacol. 2006 Nov 30;72(11):1622-31
pubmed: 16846592
Methods Mol Biol. 2012;809:105-20
pubmed: 22113271
Genome Biol. 2013 Apr 25;14(4):R36
pubmed: 23618408
EMBO J. 2012 Jun 13;31(12):2714-36
pubmed: 22617422
Epigenetics Chromatin. 2015 Feb 14;8:7
pubmed: 25784959
Nucleic Acids Res. 2016 Jan 4;44(D1):D1023-31
pubmed: 26590405
Genome Biol. 2019 Jan 3;20(1):1
pubmed: 30606230
Biotechniques. 2006 Dec;41(6):694, 696, 698
pubmed: 17191611
Biomed Res Int. 2020 Feb 19;2020:7149408
pubmed: 32149126
Cell. 2014 Oct 23;159(3):623-34
pubmed: 25417112
Mol Cell Biol. 2012 May;32(9):1654-70
pubmed: 22371484
J Biol Chem. 2016 Nov 18;291(47):24538-24550
pubmed: 27694442

Auteurs

Ruisheng Song (R)

Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School Boston, MA 02115, USA.

Kevin Struhl (K)

Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School Boston, MA 02115, USA. kevin@hms.harvard.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH